CLINICAL_TRIALS
research
· 2026-02-02
Clinical Trial Update: Open-label Extension Study to Evaluate Metreleptin in Patients With Partial Lipodystrophy [Phase 3]
Summary
Open-label extension Phase 3 trial evaluating metreleptin in patients with familial partial lipodystrophy, currently recruiting.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Amryt Pharma | Conditions: Familial Partial Lipodystrophy | Phase 3 | Status: RECRUITING